MedPath

Comparison of Enerziar and Trelegy, Single inhaler triple therapy (SITT), in asthma

Not Applicable
Recruiting
Conditions
asthma
Registration Number
JPRN-UMIN000046368
Lead Sponsor
Kindai University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who have difficulty inhaling by theirself 2) Patients who are unable to perform lung function tests. 3) For example, patients with end-stage cancer, severe heart failure, liver cirrhosis, respiratory failure, etc. 4) Current smokers, pregnant women, under 19 years old

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
QOL scores and forced expiratory volume in 1 second. Background factors of the medication selected as better.
Secondary Outcome Measures
NameTimeMethod
Various pulmonary function test items, FeNO levels, and frequency of adverse events.
© Copyright 2025. All Rights Reserved by MedPath